Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-067929
Filing Date
2025-07-15
Accepted
2025-07-15 07:00:59
Documents
3
Period of Report
2025-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2520965d1_6k.htm 6-K 9383
2 EXHIBIT 99.1 tm2520965d1_ex99-1.htm EX-99.1 17617
3 GRAPHIC tm2520965d1_ex99-1img001.jpg GRAPHIC 11053
  Complete submission text file 0001104659-25-067929.txt   43506
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39997 | Film No.: 251123056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)